Coasting - What is the best formula?

Human Reproduction

Volumn 18, Issue 5, 2003, Pages 937-940

  Levinsohn Tavor, O ^a,b   Friedler, S ^a,b   Schachter, M ^a,b   Raziel, A ^a,b   Strassburger, D ^a,b   Ron El, R ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Coasting; Guidelines; IVF; Ovarian hyperstimulation syndrome

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN DERIVATIVE; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; NAFARELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN;

CLINICAL TRIAL; COASTING; DRUG COST; DRUG EFFICACY; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; FERTILIZATION; HIGH RISK PATIENT; HUMAN; IMPLANTATION; INCIDENCE; INFERTILITY; INFERTILITY THERAPY; INFORMATION PROCESSING; MEDLINE; OVARY DISEASE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY; REVIEW;

FALLOPIA;

EID: 0038060443     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg230     Document Type: Review

References (20)

1. Al-Shawaf, T., Zosmer, A., Hussain, S., Tozer, A., Panay, N., Wilson, C., Lowen, A.M. and Grudzinskas, J.G. (2001) Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: A modified 'coasting' strategy based on ultrasound for identification of high-risk patients. Hum. Reprod., 16, 24-30.
2. Amso, N.N., Ahuja, K.K., Moris, N. and Shaw, R.W. (1990) The management of predicted ovarian hyperstimulation involving gonadotrophin-releasing hormone analogue with elective cryopreservation of all pre-embryos. Fertil. Steril., 53, 1087-1090.
3. Asch, R.H., Li H.P., Balmaceda, J.P., Weckstein, L.N. and Stone, S.C. (1991) Severe ovarian hyperstimulation syndrome in assisted reproductive technology: Definition of high risk groups. Hum. Reprod., 10, 1395-1399.
4. Asch, R., Ivery, G., Goldsman, M., Fredrick, J.L., Stone, S.C. and Balmaceda, J.P. (1993) The use of intravenous albumin in patients at high risk of ovarian hyperstimulation syndrome. Hum. Reprod., 8, 1015-1020.
5. Benavida, C.A., Davis, O., Kligman, I., Moomjy, M., Liu, H.C. and Rosenwaks, Z. (1997) Withholding gonadotrophin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil. Steril., 67, 724-727.
6. Dhont, M., Van Der Straeten, F. and De Sutter, P. (1998) Prevention of severe ovarian hyperstimulation by coasting. Fertil. Steril., 70, 847-850.
7. Egbase, P.E., Al Sharhan, M. and Grudzinskas, J.G. (1999) Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: A prospective randomized study. Hum. Reprod., 14, 1421-1425.
8. Egbase, P.E., Al Sharhan, M., Berlingieri, P. and Grudzinskas, J.G. (2000) Serum estradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproductive treatment. Hum. Reprod., 15, 2082-2086.
9. Egbase, P.E., Al Sharhan, M. and Grudzinskas, J.G. (2002). 'Early coasting' in patients with polycystic ovarian syndrome is consistent with good clinical outcome. Hum. Reprod., 17, 1212-1216.
10. Enskog, A., Henriksson, M., Unander, M., Nilsson, L. and Brannstrom, M. (1999) Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil. Steril., 71, 808-814.
11. Fluker, M.R., Hooper, W.M. and Yuzpe, A.A. (1999) Withholding gonadotrophin ('coasting') to minimize the risk of ovarian hyperstimulation during superovulation and in vitro fertilization-embryo transfer cycles. Fertil. Steril., 71, 294-301.
12. Isaza, V., Garcia-Velasco, J.A., Aragones, M., Remohi, J., Simon, C. and Pellicer, A. (2002) Oocyte and embryo quality after coasting: The experience from oocyte donation. Hum. Reprod., 17, 1777-1782.
13. Lee, C., Tummon, I., Martin, J., Nisker, J., Power, S. and Tekpetey, F. (1998) Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome? Hum. Reprod., 13, 1157-1158.
14. Rabinovici, J., Kushnir, O., Shalev, J., Goldenberg, M. and Blankstein, J. (1987) Rescue of menotrophin cycles prone to develop ovarian hyperstimulation. Br. J. Obstet. Gynaecol., 94, 1098-1102.
15. Sher, G., Salem, R., Feinman, M., Dodge, S., Zouves, C. and Knutzen, V. (1993) Eliminating the risk of life-endangering complications following overstimulation with menotrophin fertility agents: A report on women undergoing in vitro fertilization and embryo transfer. Obstet. Gynecol., 81, 1009-1011.
16. Sher, G., Zouves, C., Feinman, M. and Maassarani, G. (1995) 'Prolonged coasting': An effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum. Reprod., 10, 3107-3109.
17. Tortoriello, D.V., McGovern, P.G., Colon, J.M., Loughlin, J. and Santoro, N. (1998) "Coasting" does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil. Steril., 69, 454-460.
18. Ulug, U., Bahceci, M., Erden, H.F., Shalev, E. and Ben-Shlomo, I. (2002) The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum. Reprod., 17, 310-312.
19. Urman, B., Pride, S.M. and Ho Yuen, B. (1992) Management of overstimulated gonadotrophin cycles with a controlled drift period. Hum. Reprod., 7, 213-217.
20. Waldenstrom, U., Kahn, J., Marsk, L. and Nilsson, S. (1999) High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: A multicentre study. Hum. Reprod., 14, 294-297.